Key Takeaways for Premier Practice Owners
- Premier dental practices with $1.5M+ in revenue usually face 2 main exit paths: doctor-to-doctor sales or DSO/private equity affiliations, and each path uses different valuation methods and creates different post-close realities.
- DSO valuations rely on EBITDA multiples (currently about 5x–12x) instead of collections percentages, so a CPA-led, diligence-grade EBITDA analysis can be essential to defend value during buyer review.
- Most DSO deals require 3–5 years of post-close employment plus 15–30% equity rollover, so owners benefit from evaluating both the cash at close and the long-term equity potential before signing.
- McLerran & Associates runs a competitive 45–60 day process that typically generates about 10 vetted offers, which can produce roughly 30% higher valuations and an 85–90% close rate compared with many industry outcomes.
- Schedule a free, confidential discovery call with McLerran & Associates to see a side-by-side valuation and decide which transition path can align with your goals and timing.
How DSOs and Private Buyers Think About Dental Practice Value
A DSO affiliation is a transaction where a practice owner sells some or all ownership in the practice to a Dental Service Organization, a company that provides non-clinical business support such as billing, HR, marketing, and compliance to affiliated offices. The DSO usually takes over administrative operations while the dentist continues practicing under a multi-year employment agreement and often keeps a minority equity stake in the acquiring platform.
Practice value usually falls within a range rather than a single number. That range can be shaped by profitability, transferability, specialty, and local market conditions. In doctor-to-doctor sales, value is often expressed as a percentage of annual collections or a multiple of net cash flow. In DSO and private equity deals, value is expressed as a multiple of EBITDA, which stands for Earnings Before Interest, Taxes, Depreciation, and Amortization and represents the practice’s operating profit after removing non-recurring and owner-specific expenses.
A CPA-led EBITDA analysis usually forms the starting point for a valuation that can stand up to buyer scrutiny. This work unpacks every add-back, which is a legitimate expense that inflates costs on paper but does not reflect the true cost of running the practice under new ownership. Common add-backs include:
| Add-Back Category | Description | Typical Impact |
|---|---|---|
| Owner compensation above market | Salary paid to the owner-doctor above what an associate replacement would cost | Often the largest single add-back |
| Personal vehicle expenses | Auto lease or depreciation run through the practice | Moderate; varies by owner |
| Excess retirement contributions | Owner-directed contributions above a normalized level | Moderate |
| Family members on payroll | Compensation to relatives not performing market-rate roles | Varies widely |
| Non-recurring expenses | One-time equipment purchases, legal fees, or renovation costs | Situational; can be significant |
| Excess continuing education | CE costs above a normalized benchmark | Minor to moderate |
| Personal insurance premiums | Life or disability insurance paid through the practice | Minor to moderate |
Several practice-specific factors can also move valuation in a meaningful way. Hygiene revenue above 30% of total collections can support premium multiples because recurring hygiene visits suggest a stable, transferable patient base. In contrast, practices where the owner-doctor performs 90% or more of production can see lower multiples because buyers account for the risk that revenue may leave with the seller. Specialty can also influence value. Oral surgery, orthodontics, and pediatric dentistry often command higher multiples than general dentistry, although buyer demand currently remains strong across many segments.
How DSOs Use EBITDA Multiples and Equity to Price Practices
Once a practice reaches roughly $1M to $1.5M in EBITDA, valuation usually shifts from percentage-of-collections to EBITDA multiples, and private equity backed DSO platforms often become the main buyer group. The multiple applied to EBITDA is not fixed. It can vary with practice size, transferability, specialty, hygiene strength, associate structure, and overall market conditions.
Dental practice EBITDA multiples ranged from about 5x–9x in 2022 and about 5x–12x in 2026, with higher ranges for larger platforms, according to Sorso. These ranges can remain attractive for scaled practices.
The quality of the EBITDA analysis often determines whether a valuation survives diligence or gets reduced. DSO buyers usually conduct a formal quality-of-earnings, or QoE, review, which is a line-by-line audit of every add-back and revenue assumption. A weak or unsupported valuation can be re-traded, meaning the buyer reduces the agreed price after the letter of intent, or LOI, is signed, at a point when the seller has less leverage.
McLerran & Associates prepares diligence-grade EBITDA analysis before the practice goes to market so the numbers are ready for a buyer’s QoE team. In one documented case, a free valuation estimated a practice at $2.5M. McLerran valued it at $4.5M, and the practice ultimately sold for $5.25M after a competitive process.
Equity structure forms a second major dimension of DSO valuation. Not all equity behaves the same way for an owner.
| Equity Type | How It Works | Upside Potential | Key Risk |
|---|---|---|---|
| Joint-Venture (JV) Equity | Seller keeps ownership at the individual practice level and receives ongoing distributions from that practice’s profits | Moderate; tied to single-practice performance | Lower ceiling; distributions depend on practice-level margins |
| Holding-Company Equity | Seller receives shares in the broader DSO platform and usually does not receive ongoing distributions but participates in platform-level growth | Higher ceiling; value can multiply at a future recapitalization | No current income; value depends on DSO performance and exit timing |
DSO transactions typically close with about 60% to 75% cash at close and 15% to 30% rollover equity, and rollover is effectively mandatory in many structures. That rollover equity usually vests or pays out when the buyer exits, often 5 to 7 years after closing. Because as much as 40% of a DSO deal can be paid in equity instead of cash, many owners choose to evaluate the DSO platform as carefully as they would any major investment.
Post-Close Work Commitments and the Dentist “2-Year Rule”
The informal “2-year rule” describes the minimum post-close employment commitment that many DSO buyers request from selling dentists. In practice, the standard can run longer. Sellers in DSO transactions often remain as clinical associates for 1 to 5 years after closing and are usually paid on personal production rather than overall practice earnings.
Post-close contract terms can include several provisions that shape the seller’s experience after the deal closes.
- Work-back employment agreement: A multi-year contract that requires the seller to continue practicing at the affiliated location, usually at a production-based compensation rate.
- Non-compete covenant: A restriction that limits the seller’s ability to practice within a defined geographic radius for a set period.
- Clinical autonomy provisions: Contract language that addresses the DSO’s ability to influence treatment planning, staffing, and scheduling. State corporate-practice-of-dentistry laws, which vary widely, can limit how much operational control a DSO may exercise, and provisions that allow interference with clinical judgment can be void or unenforceable in some states.
- Management Services Agreement (MSA): A long-term contract between the dentist-owned professional entity and the DSO that can be difficult to unwind after closing.
Favorable post-close terms can include a later earnout start date to allow for integration, pro-rata earnout provisions, and clear clinical autonomy language. McLerran & Associates focuses on these points during LOI negotiation. Owners who sign buyer-drafted agreements without sell-side representation often find that these terms are hard to change later.
Economic Life After a DSO Sale
The headline valuation multiple represents only one part of a DSO deal’s overall value. The amount an owner actually receives after taxes, after the post-close employment period, and after any equity event can depend on deal structure and DSO performance over time. Because these variables can interact in complex ways, comparing deals only by headline multiple can be misleading.
McLerran models after-tax cash flows across several time horizons so owners can compare options using projected dollars rather than just headline figures.
The table below illustrates how after-tax cash flow ranges can differ by time horizon for a hypothetical premier practice. These ranges are for education only. Actual outcomes depend on deal structure, tax profile, DSO performance, and individual circumstances, so owners should consult their CPA and legal advisors.
| Time Horizon | Key Cash-Flow Components | Primary Variables |
|---|---|---|
| 3 Years | Cash at close after tax, post-close production compensation, and any earnout payments | Cash-at-close percentage, earnout achievability, and production compensation rate |
| 5 Years | All 3-year components plus any first equity distribution or partial recapitalization event | DSO platform growth, recapitalization timing, and equity structure, such as JV or holdco |
| 7 Years | All 5-year components plus a likely primary equity exit event and the end of most employment agreements | DSO exit multiple at recapitalization, equity dilution, and platform financial health |
| 10 Years | Full liquidity from all equity events and post-employment income from retained real estate or other assets | Second-bite equity realization, pre-sale tax planning, and real estate strategy |
Earnout structures, which are contingent payments tied to post-close financial targets, can require careful attention. Dental earnouts often represent 10% to 25% of total consideration, are measured annually on EBITDA or collections, and can benefit from seller protections such as same-store measurement, no corporate overhead allocation, change-of-control acceleration, and independent dispute resolution. McLerran often negotiates for non-punitive earnout structures, including pro-rata provisions so a near-miss on an EBITDA target still pays most of the earnout, and later start dates to allow for integration.
Tax structure can be a major driver of after-tax proceeds. In dental practice asset sales, goodwill is usually taxed at long-term capital-gains rates, which are roughly 20% plus a 3.8% net investment income surtax. Equipment can trigger ordinary-income taxation through depreciation recapture, and non-compete covenants are also taxed as ordinary income. Federal capital gains rates in 2026 top out at 20% plus the 3.8% Net Investment Income Tax for a combined 23.8% on long-term capital gain from goodwill, while ordinary income rates can reach 37% on personal service compensation. Purchase-price allocation, which is how the total deal value is divided among asset classes on IRS Form 8594, can shift large amounts between tax buckets.
Comparing Private-Buyer and DSO Paths for $1.5M–$3M Practices
Owners in the $1.5M to $3M revenue range sit in what McLerran calls the “Venn diagram middle,” where both doctor-to-doctor sales and DSO affiliations can be realistic options. The better path can depend on the owner’s goals, practice profile, and financial priorities. The comparison below uses general ranges, and actual figures can vary by practice and market.
| Dimension | Private Buyer (Doctor-to-Doctor) | DSO / Private Equity Affiliation |
|---|---|---|
| Valuation method | Percentage of collections or multiple of net cash flow | Multiple of adjusted EBITDA |
| Typical cash at close | Generally higher percentage of total price, usually bank-financed by the buyer | About 60%–85% of total consideration depending on practice tier |
| Equity component | None, so the owner usually exits fully at close | About 15%–30% rollover equity is common, and some structures reach up to 40% |
| Post-close work requirement | Often 4–8 weeks for a walk-away sale, longer for partnership or vest-out models | About 3–5 years of employment is typical |
| Headline valuation potential | Can be strong for well-run practices, with a ceiling set by individual buyer financing capacity | Often higher ceiling for practices with strong EBITDA, and a competitive process can lift value further |
| Best fit | Owner seeking a clean exit, legacy preservation, and a shorter transition | Owner seeking maximum total economic outcome, infrastructure support, or growth capital |
Because McLerran & Associates works both pathways in roughly equal measure, with an approximately 50/50 split across about 2,000 completed transactions, it can provide a genuine side-by-side valuation for owners in this middle range and quantify the practice’s worth in both markets before any path is chosen.
How McLerran Runs a Competitive, Seller-Focused DSO Process
A practice owner usually sells once in a career, while a DSO negotiates acquisitions every week. That gap in information, experience, and leverage can be significant, and McLerran & Associates focuses on narrowing it for sellers.
The firm’s DSO sell-side process typically runs 45 to 60 days and often generates about 10 offers from a vetted pool of qualified buyers. Poorly run or undercapitalized DSOs are screened out and do not reach the table. The process narrows from initial offers to in-person meetings with the top 1 to 3 finalists, and McLerran forecasts each finalist’s deal structure so the owner can compare projected after-tax outcomes side by side.
This competitive approach can help McLerran clients achieve approximately 30% higher valuations than owners who sell without representation. As the firm describes its role, it focuses on selling practices rather than simply listing them.
Buyer vetting criteria include:
- Demonstrated profitability of the DSO platform as a whole, not just individual locations
- Revenue growth trajectory at existing affiliated offices
- Strength and experience of the management team
- Track record of the private equity sponsor, including prior dental platform exits
- Post-close support model, including compliance, HR, payroll, IT, and growth infrastructure
- Reputation among dentists who have previously affiliated with the platform
After the LOI is signed, McLerran provides quality-of-earnings defense through diligence by standing behind the EBITDA it underwrote and reminding buyers that other vetted bidders remain available if the agreed value is challenged without cause. This advocacy can reduce the risk of re-trading after the seller’s leverage has declined.
McLerran’s transaction rate of about 85% to 90%, compared with industry norms closer to 35% to 40% and do-it-yourself close rates that can fall as low as 15% to 20%, reflects the combined effect of diligence-grade valuation, a competitive process, and end-to-end representation.
Frequently Asked Questions
Should I sell to a private buyer or a DSO?
The better path can depend on your practice size, profitability, and personal goals. Practices in the $1M to $1.5M revenue range often fit a doctor-to-doctor sale well because individual buyers can usually finance the acquisition and the seller may want a clean, shorter transition. Practices above $3M in revenue often lean toward the DSO path, where EBITDA-based multiples and competitive buyer pools can support higher total economic outcomes. Owners in the $1.5M to $3M middle range can often pursue either path. Because McLerran works both markets in roughly equal measure, it can provide a side-by-side valuation that shows your practice’s worth in both the private-buyer and DSO markets so you can decide with clearer information.
How do I know if a DSO is a good partner?
DSO quality can vary widely, and that difference can influence whether your retained equity becomes worth multiples of its original value or significantly less. Helpful evaluation points include whether the DSO’s overall platform is profitable, whether revenue at existing affiliated offices is still growing, whether the management team has relevant experience, and whether the private equity sponsor has successfully exited dental platforms before. McLerran vets buyers against these criteria and has blacklisted DSOs known for poor post-close environments, including undercapitalized buyers that emerged when capital flooded the space after COVID. Owners who work with McLerran do not have to navigate these questions alone.
What is my practice actually worth, and why do free valuations fall short?
A free valuation usually serves as a lead-generation tool and often produces a quick estimate that may not survive buyer scrutiny. When a buyer’s quality-of-earnings team audits the add-backs and finds unsupported figures, the agreed price can be reduced after the LOI is signed, at a point when the seller has less leverage. McLerran’s CPA-led EBITDA analysis is built to diligence standards before the practice goes to market, so the number is designed to hold when buyers examine it closely. The firm has evaluated more than 10,000 dental practices and has seen the gap between a free valuation and a defensible one reach millions of dollars in individual transactions.
What happens to my staff and patients after I sell to a DSO?
Fit can matter as much as price. A DSO affiliation creates a long-term relationship, and the buyer’s post-close support model, clinical culture, and operational approach can shape the experience of your staff and patients after you step back. McLerran works to secure a strong financial outcome while identifying buyers whose strategy and support model can protect the legacy you have built. The firm also acts as a buffer during the period between LOI and close, which can help protect staff relationships and goodwill at a time when unmanaged communication might cause anxiety or patient attrition.
Conclusion: Turning a Once-in-a-Career Sale into a Structured Process
Selling a dental practice is usually a once-in-a-career decision. The four-part journey of understanding your options, creating competition, finding the right fit, and maximizing your outcome functions as a structured process that can narrow the information gap between a practice owner and a DSO that negotiates deals every week.
McLerran & Associates has guided about 2,000 practice owners through this process and has closed roughly $2B in transaction volume with an approximately 85% to 90% transaction rate. The firm works exclusively on the sell side, so its only client is the practice owner, and it operates nationally.
Demand for premier, Class A dental practices currently remains strong, and valuations sit near historically high levels in many markets. Many owners find that the right time to understand their options is before they feel pressure to act.
Schedule a free, confidential discovery call with McLerran & Associates by calling (512) 900-7989, emailing info@dentaltransitions.com, or visiting dentaltransitions.com/contact-us. The conversation is confidential, there is no obligation, and if you are not ready to sell today, McLerran can update your valuation for free a year later rather than encourage a sale before you are ready.
